KR920006783B1 - Process for preparing raticide 4-hydroxy coumarin derivatives - Google Patents

Process for preparing raticide 4-hydroxy coumarin derivatives Download PDF

Info

Publication number
KR920006783B1
KR920006783B1 KR1019910015769A KR910015769A KR920006783B1 KR 920006783 B1 KR920006783 B1 KR 920006783B1 KR 1019910015769 A KR1019910015769 A KR 1019910015769A KR 910015769 A KR910015769 A KR 910015769A KR 920006783 B1 KR920006783 B1 KR 920006783B1
Authority
KR
South Korea
Prior art keywords
formula
phenyl
solvent
hydroxy
compound
Prior art date
Application number
KR1019910015769A
Other languages
Korean (ko)
Inventor
장봉석
Original Assignee
국보제약 주식회사
안석원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 국보제약 주식회사, 안석원 filed Critical 국보제약 주식회사
Priority to KR1019910015769A priority Critical patent/KR920006783B1/en
Application granted granted Critical
Publication of KR920006783B1 publication Critical patent/KR920006783B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/12Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7

Abstract

A method for preparing 4-hydroxy-3-[1,2,3,4-tetrahydro-3-(4-( 4- trifluoromethyl-benzyloxy)phenyl)-1-naphthyl coumarin of formula (I) comprises reacting a cpd. of formula (II) with trifluoro methyl benzene halide in an alcoholic solvent in the presence of an alkali salt of t-butylalcohol. The cpd. of formula (II) is new. 4-Hydroxy coumarin derivs. of formula (I) are useful as a rodenticidal anticoagulant.

Description

항혈액응고성 살서제인 4-하이드록시쿠마린 유도체의 제조방법Method for preparing 4-hydroxycoumarin derivative, an anticoagulant killing agent

본 발명은 다음 구조식(Ⅰ)로 표시되는 항혈액응고성 살서제인 4-하이드록시-3-[1,2,3,4-테트라하이드로-3-{4-(4-트리풀루오로메칠-벤질옥시)페닐}-1-나프틸]쿠마린의 신규 제조방법에 관한 것이다.The present invention relates to 4-hydroxy-3- [1,2,3,4-tetrahydro-3- {4- (4-tripuloolomethyl-), which is an anticoagulant killing agent represented by the following structural formula (I): A novel process for producing benzyloxy) phenyl} -1-naphthyl] coumarin.

상기 구조식(Ⅰ)의 화합물은 공지화합물로서 예를들면 대한민국 특허공고 제91-404호에 그 제조방법에 기재되어 있다. 이 방법에 의하면, 4-하이드록시쿠마린을 다음 일반식(A)의 화합물과 열축합시키거나,The compound of formula (I) is a known compound, for example, described in the preparation method thereof in Korean Patent Publication No. 91-404. According to this method, 4-hydroxycoumarin is thermally condensed with a compound of the general formula (A),

다음 일반식(C)의 1-하이드록시-3-(p-할로디페닐)테트라린을 CuCN과 반응시켜서 상응하는 올레핀을 생성한다음 이 생성된 올레핀을 4-하이드록시쿠마린과 커플링시키거나,1-hydroxy-3- (p-halodiphenyl) tetrarin of formula (C) is then reacted with CuCN to produce the corresponding olefin and then the resulting olefin is coupled with 4-hydroxycoumarin or ,

또는 1-케토-3-(p-할로디페닐)-테트라린을 CuCN과 반응시킨 다음 생성된 시아노테트랄론을 상응하는 1-하이드록시화합물로 환원시키고, 상기 하이드록시화합물을 4-하이드록시쿠마린과 축합시켜서 제조하였다.Or reacting 1-keto-3- (p-halophenyl) -tetrarin with CuCN and then reducing the resulting cyanotetralone to the corresponding 1-hydroxy compound, the hydroxy compound being 4-hydroxy Prepared by condensation with coumarin.

그러나, 이들 방법은 실제로 그 중간단계의 반응물질들 및 최종생성물질을 제조하는데 공정도 대단히 복잡하고, 그 조작이 복잡할 뿐만아니라, 그 제조수율도 또한 낮아서 상업적 생산에는 문제가 있었다.However, these methods are actually very complicated in the preparation of the intermediate reactants and the final product, the operation is not only complicated, but also the production yield is low, there is a problem in commercial production.

본 발명자들은 이러한 기존의 제조방법의 문제점을 해결하기 위하여 오랜 연구를 행한 결과, 온화한 조건하에서 높은 수율로 목적화합물인 상기 구조식(Ⅰ)의 화합물을 제조할 수 있는 새로운 제조방법을 발명하였다.The present inventors have conducted a long study to solve the problems of the existing production method, and as a result, invented a new production method capable of producing the compound of formula (I) as a target compound in high yield under mild conditions.

본 발명을 다음에서 상세히 설명한다.The invention is explained in detail in the following.

1-페닐아세틸할라이드(XI)를 알콕시벤젠(Ⅹ)과 함께 염화알루미늄촉매 존재하에 반응시켜서 1-(4'-알콕시)페닐-2-페닐-1-에탄올(Ⅸ)를 제조한다. 이 반응은 염화메틸렌과 같은 용매존재하에 반응시킴이 바람직하다. 반응은 약 10도 이하에서 반응시킴이 바람직하다. 반응시간은 1-24시간 반응시킨다. 반응후에는 물이나 기타 용매로 세척한후 염화메틸렌등의 용매로 추출한후 황산마그네슘과 같은 건조제로 건조시킨후 용매를 제거하고 필요하면 재결정등의 통상의 방법으로 정제하여 목적화합물을 제조한다.1-phenylacetyl halide (XI) is reacted with an alkoxybenzene in the presence of an aluminum chloride catalyst to prepare 1- (4'-alkoxy) phenyl-2-phenyl-1-ethanol. This reaction is preferably carried out in the presence of a solvent such as methylene chloride. The reaction is preferably reacted at about 10 degrees or less. The reaction time is reacted for 1-24 hours. After the reaction, the mixture is washed with water or other solvents, extracted with a solvent such as methylene chloride, dried with a drying agent such as magnesium sulfate, and then the solvent is removed and, if necessary, purified by a conventional method such as recrystallization to prepare a target compound.

앞에서 얻어진 케톤유도체(Ⅸ)를 알킬할로아세테이트 존재하에 환원시켜서 3-하이드록시-3-(4'-알콕시)페닐-4-페닐부타노인산 알킬에스테르(Ⅷ)를 제조한다. 환원제로는 아연등 통상의 환원제를 사용한다. 이 반응은 벤젠, 톨루엔등의 방향족 탄화수소 용매 및 요오드 존재하에 환류시킨다. 반응은 약 30분 내지 5시간 행한다. 앞에서 얻어진 알콜 유도체(Ⅷ)를 염화메틸렌 등과 같은 용매중에서 트리알킬실란 및 트리풀루오로아세트산 및 보론트리풀루오라이드와 함께 반응시켜서 3-워치의 하이드록시키를 환원시켜서 3-(4'-알콕시)페닐-4-페닐부타노인산 알킬에스테르(Ⅶ)를 제조한다. 반응은 환류조건하에 약 3-24시간 반응을 행한다.The ketone derivative (v) obtained above is reduced in the presence of an alkyl halo acetate to prepare 3-hydroxy-3- (4'-alkoxy) phenyl-4-phenylbutanoic acid alkyl ester (v). As a reducing agent, ordinary reducing agents such as zinc are used. This reaction is refluxed in the presence of iodine and an aromatic hydrocarbon solvent such as benzene and toluene. The reaction is carried out for about 30 minutes to 5 hours. The alcohol derivatives obtained above were reacted with trialkylsilane, trifluuroacetic acid and borontripulolide in a solvent such as methylene chloride to reduce the hydroxy key of the 3-watch to yield 3- (4'-alkoxy ) Phenyl-4-phenylbutanophosphate alkyl ester (i) is manufactured. The reaction is carried out under reflux conditions for about 3-24 hours.

반응후 염화메틸렌으로 추출한 후 물로 세척하고 통상의 방법으로 건조시키고 용매를 제거하여 3-(4'-알콕시)페닐-4-페닐부타노인산 알킬에스테르(Ⅶ)를 제조한다. 앞에서 얻어진 에스테르 유도체(Ⅶ)를 메탄올, 에탄올 또는 이들 용매와 물의 혼합용매에서 수산화 칼륨, 수산화 나트륨등과 같은 알칼리로 가수분해시켜서 3-(4'-알콕시)페닐-4-페닐부타노인산(Ⅵ)을 제조한다. 이때 가수분해조건은 통상의 에스테르 가수분해의 조건을 사용한다.After the reaction, the mixture was extracted with methylene chloride, washed with water, dried in a conventional manner, and the solvent was removed to prepare 3- (4'-alkoxy) phenyl-4-phenylbutanoic acid alkyl ester (Ⅶ). The ester derivative (v) obtained above was hydrolyzed with an alkali such as potassium hydroxide, sodium hydroxide in methanol, ethanol or a mixed solvent of these solvents and water to give 3- (4'-alkoxy) phenyl-4-phenylbutanoic acid (VI). ). At this time, the hydrolysis conditions use the conditions of ordinary ester hydrolysis.

앞에서 얻어진 부타노인산 유도체(Ⅵ)를 염화주석존재하에 오염화인으로 처리하여 환원시켜서 3-(4'-알콕시)페닐-1-테트라론(Ⅴ)을 제조한다. 이때 반응온도는 충분히 냉각시키며 0-10도에서 행한다. 반응후 통상의 방법으로 추출 및 정제 및 건조시킨다. 앞에서 얻어진 테트라론 유도체(Ⅴ)를 소디움보로하이드라이드와 같은 환원제로 환원시켜서 3-(4'-알콕시)페닐-1-테트라올(Ⅳ)을 제조한다.Butanophosphoric acid derivative (VI) obtained above is treated with phosphorus pentachloride in the presence of tin chloride to reduce 3- (4'-alkoxy) phenyl-1-tetrarone (V). At this time, the reaction temperature is sufficiently cooled and performed at 0-10 degrees. After the reaction, extraction, purification and drying are carried out by conventional methods. The tetraron derivative (V) obtained above is reduced with a reducing agent such as sodium borohydride to prepare 3- (4'-alkoxy) phenyl-1-tetraol (IV).

환원조건은 통상의 조건을 사용하며 환원후 통상의 용매로 추출하고 중화 및 건조시키고 용매를 제거하여 목적화합물을 제조한다. 앞에서 제조한 테트라올 유도체((Ⅳ)를 4-하이드록시쿠마린과 반응시켜서 4-하이드록시-3-[1,2,3,4-테트라하이드로-3-(4-알콕시페닐)-1-나프틸]-쿠마린(Ⅲ)을 제조한다. 반응은 약 100-110도에서 1-5시간 환류시켜서 행한다. 반응후에는 통상의 방법으로 추출, 건조 여과 또는 용매를 제거하여 목적화합물을 제조한다. 앞에서 얻어진 쿠마린화합물(Ⅲ)을 아세트산 및/또는 취화수소산등과 같은 할로겐화수소산과 5-10시간 환류하여 알콕시기를 가수분해시켜서 4-하이드록시-3-[1,2,3,4-테트라하이드로-3-(4-하이드록시페닐)-1-나프틸]쿠마린(Ⅱ)을 제조한다. 가수분해 조건은 통상의 에테르의 가수분해 조건하에서 행한다.Reducing conditions are used in the usual conditions, after reduction to extract the usual solvent, neutralized and dried, and removing the solvent to prepare the target compound. 4-hydroxy-3- [1,2,3,4-tetrahydro-3- (4-alkoxyphenyl) -1-nap by reacting the tetraol derivative (IV) prepared above with 4-hydroxycoumarin Til] -coumarin (III) is prepared by reaction at reflux for about 1-5 hours at about 100-110 ° C. After the reaction, the desired compound is prepared by extraction, drying filtration or removing the solvent in a conventional manner. The resulting coumarin compound (III) is refluxed with a halogenated acid such as acetic acid and / or hydrochloric acid for 5-10 hours to hydrolyze the alkoxy group to yield 4-hydroxy-3- [1,2,3,4-tetrahydro-3. -(4-hydroxyphenyl) -1-naphthyl] coumarin (II) is produced Hydrolysis conditions are performed under the conditions of hydrolysis of ordinary ethers.

앞에서 얻어진 쿠마린화합물(Ⅱ)을 트리풀루오로메틸벤젠할라이드와 반응시켜서 4-하이드록시-3-[1,2,3,4-테트라하이드로-3-[4-(4-트리풀루오로메틸벤젠옥시)페닐]-1-나프틸]-쿠마린(Ⅰ)을 제조한다.The above-mentioned coumarin compound (II) is reacted with trifluorofluoromethylbenzene halide to give 4-hydroxy-3- [1,2,3,4-tetrahydro-3- [4- (4-trifluorofluoromethyl Benzeneoxy) phenyl] -1-naphthyl] -coumarin (I) is prepared.

반응은 알콜류 바람직하게는 t-부틸알콜의 알카리금속의 알콕사이드존재하에 알콜류용매중에서 트리플루오로메틸벤젠할라이드를 반응시킨다. 반응후에는 통상의 방법으로 추출, 건조, 세척 및 용매를 제거하여 목적화합물을 제조한다.The reaction is reacted with trifluoromethylbenzene halide in an alcohol solvent in the presence of an alcohol, preferably an alkoxide of an alkali metal of t-butyl alcohol. After the reaction, extraction, drying, washing and removing the solvent in a conventional manner to prepare the target compound.

이를 반응식으로 나타내면 다음과 같다.This is represented by the following scheme.

식중 R 및 R1은 탄소수 1-4의 저급알킬기이며, X는 염소, 취소 또는 요오드를 나타낸다.Wherein R and R 1 are lower alkyl groups having 1 to 4 carbon atoms and X represents chlorine, cancellation or iodine.

본 발명에서 제조된 모든 중간체는 신규의 물질이다. 앞의 설명 및 다음의 실시예의 온도는 모두 섭씨온도를 나타낸다. 다음에 실시예로서 본 발명을 더욱 상세히 설명한다.All intermediates produced in the present invention are novel materials. The temperature in the previous description and in the following examples all represent degrees Celsius. Next, the present invention will be described in more detail by way of examples.

[실시예 1]Example 1

[1-(4'-메톡시)페닐-2-페닐-1-에탄온(Ⅸ)의 제조][Preparation of 1- (4'-methoxy) phenyl-2-phenyl-1-ethanone]

삼구 플라스크에 100g의 페닐 아세틸 클로라이드(XI)와 73.4g 아니솔(Ⅹ), 그리고 메칠렌 클로라이드 600㎖를 넣고, 교반시킨다. 94.9g의 알루미늄 클로라이드를 10℃이하에서 조심스럽게 소량씩 가한다음 16시간동안 교반시킨다. 반응물을 물과 염산이든 용기에 저어주면서 조심스럽게 붓는다. 물로써 반응물을 세척한뒤 메칠렌 클로라이드로 추출한다. 추출물을 황산마그네슘으로 건조시킨뒤 여과시켜 감압증류하여 용매를 제거하고 재결정하여 127.2g의 생성물을 얻는다.In a three-necked flask, 100 g of phenyl acetyl chloride (XI), 73.4 g of anisole, and 600 ml of methylene chloride are added and stirred. 94.9 g of aluminum chloride is carefully added in small portions below 10 ° C. and then stirred for 16 hours. Pour the reactants carefully, stirring the container with water and hydrochloric acid. The reaction is washed with water and extracted with methylene chloride. The extract was dried over magnesium sulfate, filtered and distilled under reduced pressure to remove the solvent and recrystallized to obtain 127.2 g of the product.

(수율 : 87% mp 71-73)(Yield 87% mp 71-73)

NMR(CDCl,) δ 3.84(S, 3H), 4.22(S, 2H), 6.91(d, 2H, J=8.5㎐), 7.22-7.34(m, 5H), 8.00(d, 2H, J=8.5㎐)NMR (CDCl,) δ 3.84 (S, 3H), 4.22 (S, 2H), 6.91 (d, 2H, J = 8.5 μs), 7.22-7.34 (m, 5H), 8.00 (d, 2H, J = 8.5 ㎐)

[실시예 2]Example 2

[3-하이드록시-3-(4'-메톡시)페닐-4-페닐 부타노익 엑시드 에스테르(Ⅷ)의 제조][Preparation of 3-hydroxy-3- (4'-methoxy) phenyl-4-phenyl butanoic acid ester]

삼구 플라스크에 134g의 실시예 1에서 얻어진 케톤 유도체(Ⅸ)와 42.6g의 아연 그리고 370㎖의 벤젠을 넣고 1시간 동안 환류시키고 108.9g의 에칠 브로모아세테이트와 0.537g의 요오드 그리고 약간량의 벤젠을 혼합해서 소량씩 가한다음 1시간 동안 환류시킨다. 실온으로 식힌뒤 15% 황산 가하고 벤젠으로 추출하여 유기층을 10% 중조로 처리하고 물로써 3차례 세척한후 황산마그네슘으로 건조시키고 감압증류시켜 용매를 제거후 잔류물을 모은다.In a three-necked flask, 134 g of the ketone derivative obtained in Example 1, 42.6 g of zinc, and 370 ml of benzene were refluxed for 1 hour, 108.9 g of ethyl bromoacetate, 0.537 g of iodine, and a small amount of benzene. Add a small amount by mixing and reflux for 1 hour. After cooling to room temperature, 15% sulfuric acid was added, extracted with benzene, the organic layer was treated with 10% sodium bicarbonate, washed three times with water, dried over magnesium sulfate, and distilled under reduced pressure to remove the solvent.

(수율 96.6%) 179.8%(Yield 96.6%) 179.8%

NMR(CDCl,) δ 1.08(t, 3H), 3.76(S, 2H), 3.81(S, 3H), 3.94-4.01(q, 2H), 4.21(S, 2H), 6.90(d, 2H, J=8.5㎐), 7.21-7.32(m, 5H), 7.98(d, 2H, J=8.5㎐)NMR (CDCl,) δ 1.08 (t, 3H), 3.76 (S, 2H), 3.81 (S, 3H), 3.94-4.01 (q, 2H), 4.21 (S, 2H), 6.90 (d, 2H, J = 8.5 Hz), 7.21-7.32 (m, 5H), 7.98 (d, 2H, J = 8.5 Hz)

[실시예 3]Example 3

[3-(4'-메톡시)페닐-4-페닐 부타노익에시드 에스테르(Ⅶ)의 제조][Preparation of 3- (4'-methoxy) phenyl-4-phenyl butanoic acid ester]

삼구 플라스크에 250g의 실시예 2에서 얻어진 알콜유도체(Ⅷ)를 300㎖의 메칠렌클로라이드에 녹여넣고 105.5g의 트리에칠 실란과 376.23g의 트리풀루오르아세트산과 3㎖의 보론트라풀로리이드를 가한다. 이 용액을 8시간 동안 환류시킨후 30% 탄산칼륨으로 씻어준다. 메칠렌 클로라이드로 추출한 다음 물로 두번 세척하고 황산마그네슘으로 건조시킨 다음 여과하고 용매를 제거한다.In a three-necked flask, 250 g of the alcohol derivative obtained in Example 2 was dissolved in 300 ml of methylene chloride, and 105.5 g of triethyl silane, 376.23 g of trifluoacetic acid, and 3 ml of borontrapulolide were added. Add. The solution is refluxed for 8 hours and then washed with 30% potassium carbonate. Extract with methylene chloride, wash twice with water, dry with magnesium sulfate, filter and remove solvent.

(수율 91%)생성량 223.7%(Yield 91%) 223.7% of production

[실시예 4]Example 4

[3-(4'-메톡시)페닐-4-페닐 부타노익 에시드(Ⅵ)의 제조][Preparation of 3- (4'-methoxy) phenyl-4-phenyl butanoic acid (VI)]

삼구 플라스크에 6.0g(0.019㏖)의 실시예 3에서 얻어진 에스테르 유도체(Ⅶ)를 20㎖의 에탄올에 녹여 넣은다음 4.3g(0.076㎖)의 수산화칼륨을 물 15㎖에 녹여 가한다. 이 용액을 8시간 동안 환류한다. 실온으로 식힌다음 용매를 제거한후 물을 가하고 벤젠으로 추출후 물층을 10% 염산으로 산성화(pH 1-2)시킨다. 다시 메칠렌 클로라이드를 사용하여 추출한후 물로씻고 황산마그네슘으로 건조시킨다음 여과, 농축하여 4.62g의 생성물을 얻는다.In a three-necked flask, 6.0 g (0.019 mol) of the ester derivative obtained in Example 3 was dissolved in 20 ml of ethanol, and 4.3 g (0.076 ml) of potassium hydroxide was dissolved in 15 ml of water. This solution is refluxed for 8 hours. After cooling to room temperature, the solvent is removed, water is added, extraction is performed with benzene, and the water layer is acidified with 10% hydrochloric acid (pH 1-2). Again extracted with methylene chloride, washed with water, dried over magnesium sulfate, filtered and concentrated to yield 4.62 g of product.

(수율 85% mp 122-125)(Yield 85% mp 122-125)

NMR(CDCl,) δ 2.55-2.72(q, 2H), 2.88(d, 2H, J=7㎐), 3.40-3.51(q, 1H), 3.76(S, 3H), 6.78(d, 2H, J=9㎐), 7.00-7.05(m, 5H), 7.18(d, 2H, J=9㎐)NMR (CDCl,) δ 2.55-2.72 (q, 2H), 2.88 (d, 2H, J = 7 ′), 3.40-3.51 (q, 1H), 3.76 (S, 3H), 6.78 (d, 2H, J = 9 μs), 7.00-7.05 (m, 5H), 7.18 (d, 2H, J = 9 μs)

[실시예 5]Example 5

[3-(4'-메톡시)페닐-1-테트라론(Ⅴ)의 제조]][Preparation of 3- (4'-methoxy) phenyl-1-tetrarone (V)]]

50㎖의 삼구 플라스크에 실시예 4에서 얻어진 부타노인산 유도체(Ⅵ) 6g을 넣고 벤젠 20㎖을 넣는다. 이 용액을 ice bath 얼음, 물, 중탕에서 충분히 냉각시킨 다음 오염화인 9.3g(0.045㏖)소량씩 더한 다음 완전히 녹았을때, 얼음-물중탕으로 제거하고 1시간 동안 환류한다. 실온으로 냉각 식힌 다음 다시 얼음-물중탕으로 충분히 냉각시킨 다음 염화주석 7㎖을 벤젠에 녹여 소량씩 첨가한다. 이 용액을 0-10℃에서 1시간 동안 교반한다. 얼음/물을 첨가한 후 약간 양의 에테르와 IN염산 10㎖을 넣어 추출한후 5% KOH 10㎖물, sat-NaCl, 물로 세척한 다음 황산마그네슘으로 건조, 여과하고 용매를 제거한다.Into a 50 ml three-necked flask, 6 g of butanophosphate derivative (VI) obtained in Example 4 was added and 20 ml of benzene was added. The solution is cooled sufficiently in ice bath, water, and water bath, and then added in small amounts of 9.3 g (0.045 mol) of phosphorus, and then dissolved in an ice-water bath and refluxed for 1 hour when completely dissolved. After cooling to room temperature and cooling again with an ice-water bath, 7 ml of tin chloride is dissolved in benzene and added in small portions. The solution is stirred at 0-10 ° C. for 1 hour. After adding ice / water, the mixture was extracted with a small amount of ether and IN hydrochloric acid and extracted with 10 ml of 5% KOH, sat-NaCl, water, dried over magnesium sulfate, filtered and the solvent was removed.

(85% 수율, mp 102-105)의 생성물을 얻는다.(85% yield, mp 102-105) is obtained.

NMR(CDCl,) δ 2.68-2.75(m, 2H), 3.06(d, 2H, J=8㎐), 3.30(m, 1H), 3.71(S, 3H), 6.82(d, 2H, J=12㎐), 7.10-7.29(m, 4H), 7.4(d, 1H, J=7.5㎐), 7.98(d, 1H, J=7.5㎐)NMR (CDCl,) δ 2.68-2.75 (m, 2H), 3.06 (d, 2H, J = 8 Hz), 3.30 (m, 1H), 3.71 (S, 3H), 6.82 (d, 2H, J = 12 I), 7.10-7.29 (m, 4H), 7.4 (d, 1H, J = 7.5 kPa), 7.98 (d, 1H, J = 7.5 kPa)

[실시예 6]Example 6

[3-(4'-메톡시)페닐-1-테트라올(Ⅳ)의 제조][Preparation of 3- (4'-methoxy) phenyl-1-tetraol (IV)]

50㎖의 삼구 플라스크에 5.0g의 실시예 5에서 얻어진 테트라론 유도체(Ⅴ)과 에탄올 20㎖를 넣고 교반시키면서 소디움 보로하이드라이드 0.893g을 소량씩 첨가시킨다. 4시간 동안 저어준다음 반응물을 물에 붓고 10% 염산으로 산성화(pH2)시킨다. 메칠렌 클로라이드로 추출한후 물고 씻고, 중조로 씻고, 황산마그네슘으로 건조시킨다음 용매를 감압하에서 제거시킨다.Into a 50 ml three-necked flask, 0.8 g of sodium borohydride was added in small portions while stirring and adding 20 g of tetraron derivative (V) obtained in Example 5 and 20 ml of ethanol. Stir for 4 hours, then pour the reaction into water and acidify with 10% hydrochloric acid (pH 2). Extract with methylene chloride, wash with water, wash with sodium bicarbonate, dry over magnesium sulfate and remove the solvent under reduced pressure.

4.39g(87% 수율 mp 107-109)의 생성물을 얻는다.4.39 g (87% yield mp 107-109) of product are obtained.

NMR(CDCl,) δ 1.93(q, 2H), 2.45(m, 1H), 2.9(m, 2H), 3.8(S, 3H), 4.97(q, 1H), 6.87(d, 2H, J=9㎐), 7.1(d, 1H, J=7.5㎐), 7.18-7.29(m, 4H), 7.62(d, 1H, J=7.5㎐)NMR (CDCl,) δ 1.93 (q, 2H), 2.45 (m, 1H), 2.9 (m, 2H), 3.8 (S, 3H), 4.97 (q, 1H), 6.87 (d, 2H, J = 9 Viii), 7.1 (d, 1H, J = 7.5 μs), 7.18-7.29 (m, 4H), 7.62 (d, 1H, J = 7.5 μs)

[실시예 7]Example 7

[4-하이드록시-3-[1,2,3,4-테트라하이드로-3-(4-메톡시페닐)-1-나프틸]-쿠마린(Ⅲ)의 제조][Production of 4-hydroxy-3- [1,2,3,4-tetrahydro-3- (4-methoxyphenyl) -1-naphthyl] -coumarin (III)]

100㎖ 삼구 플라스크에 실시예 6에서 얻어진 테트라올유도체(Ⅳ) 12.64g 4-하이드록시쿠마린 8.10g, 아세트산 25㎖를 넣고 105℃로 가열하여 녹인후 교반하면서 80% 황산 3.4㎖를 방울 방울씩 가한다음 110℃에서 3시간 동안 환류시킨다. 반응 혼합물을 진공회전 증발기로 완전히 농축시키고 여기에 물을 가하고 메칠렌 클로라이드로 추출한다. 황산마그네슘으로 추출물을 건조시키고 여과한후 용매를 제거한다. 석유에테르(bp30-70)로 재결정하여 18.06g(91%수율)의 생성물을 얻는다.Into a 100 ml three-necked flask, 12.64 g of tetraol derivative (IV) obtained in Example 6, 8.10 g of 4-hydroxycoumarin and 25 ml of acetic acid were added, heated to 105 ° C, and dissolved, and 3.4 ml of 80% sulfuric acid was added dropwise while stirring. Then reflux at 110 ° C. for 3 hours. The reaction mixture is concentrated completely by vacuum rotary evaporator, to which water is added and extracted with methylene chloride. Dry the extract with magnesium sulfate, filter and remove the solvent. Recrystallization from petroleum ether (bp30-70) gave 18.06 g (91% yield) of the product.

NMR(CDCl,) δ 2.15(m, 2H), 2.56(m, 1H), 2.8-3.1(m, 2H), 3.70(S, 3H), 5.17(m, 1H), 6.63-798(m, 12H)NMR (CDCl,) δ 2.15 (m, 2H), 2.56 (m, 1H), 2.8-3.1 (m, 2H), 3.70 (S, 3H), 5.17 (m, 1H), 6.63-798 (m, 12H )

[실시예 8]Example 8

[4-하이드록시-3-[1,2,3,4-테트라하이드로-3-(4-하이드록시페닐)-1-나프틸]-쿠마린(Ⅱ)의 제조][Production of 4-hydroxy-3- [1,2,3,4-tetrahydro-3- (4-hydroxyphenyl) -1-naphthyl] -coumarin (II)]

250㎖ 삼구 플라스크에 20.0g의 실시예에서 얻어진 쿠마린 유도체(Ⅲ)와 50㎖의 아세트산, 39㎖의 47% 취산을 넣은다음 이용액을 6시간 동안 환류시킨다. 실온으로 냉각시킨후 약간량의 메칠렌클로라이드를 넣고 10% 수산화나트륨 용액으로 추출한다. 수용액을 10% 염산으로 산성화(pH2)한다음 메칠렌클로라이드로 추출한다. 유기층을 황산마그네슘으로 건조시킨다음 여과하고 감압하에서 용매를 제거한다.In a 250 ml three-necked flask, coumarin derivative (III) obtained in 20.0 g of Example, 50 ml of acetic acid and 39 ml of 47% aqueous acid was added, and the solution was refluxed for 6 hours. After cooling to room temperature, add a small amount of methylene chloride and extract with 10% sodium hydroxide solution. The aqueous solution is acidified (pH 2) with 10% hydrochloric acid and then extracted with methylene chloride. The organic layer is dried over magnesium sulfate, filtered and the solvent is removed under reduced pressure.

17-95%(93%수율)의 생성물을 얻는다.Obtain 17-95% (93% yield) of the product.

NMR(CDCl,) δ 1.92(m, 2H), 2.30(m, 1H), 2.90-3.10(m, 2H), 4.95(S, 1H), 6.75-8.0(m, 12H)NMR (CDCl,) δ 1.92 (m, 2H), 2.30 (m, 1H), 2.90-3.10 (m, 2H), 4.95 (S, 1H), 6.75-8.0 (m, 12H)

[실시예 9]Example 9

[4-하이드록시-3[1,2,3,4-테트라하이드로-3-[4-(4-트리풀루오르메칠-벤젠옥시)페닐]-1-나프틸]-쿠마린(Ⅰ)의 제조]Preparation of [4-hydroxy-3 [1,2,3,4-tetrahydro-3- [4- (4-trifluoromethyl-benzeneoxy) phenyl] -1-naphthyl] -coumarin (I) ]

질소 가스하에서 500㎖ 삼구 플라스크에 tert-부틸알콜 30㎖를 넣고 1.8g의 포타슘을 넣은후 포타슘이 다녹을때까지 교반한다. 이 용액에 실시예 8에서 얻어진 쿠마린 유도체(Ⅱ) 12.91g을 100㎖ 부틸알콜에 녹인후 더한다음 30분간 교반한다. 이 용액을 70℃로 가열된 진공회전 증발기로 용매를 제거한후 고체를 디메칠포름 아마이드 100㎖에 녹인후 8.0g의 트리플루오르메틸 벤젠 브로마이드를 더한다. 16시간동안 교반한 후 물 100㎖로 희석하고 100㎖의 에테르로 추출한다. 물로 씻어주고 황산마그네슘으로 건조한다. 여과한후 용매를 감압하에서 제거한다.30 ml of tert-butyl alcohol is added to a 500 ml three-necked flask under nitrogen gas, 1.8 g of potassium is added thereto, and the mixture is stirred until potassium is dissolved. 12.91 g of coumarin derivative (II) obtained in Example 8 was dissolved in 100 ml of butyl alcohol, and then stirred for 30 minutes. The solvent was removed by a vacuum rotary evaporator heated to 70 ° C., the solid was dissolved in 100 ml of dimethylformamide, and 8.0 g of trifluoromethyl benzene bromide was added thereto. After stirring for 16 hours, it is diluted with 100 ml of water and extracted with 100 ml of ether. Wash with water and dry with magnesium sulfate. After filtration the solvent is removed under reduced pressure.

15.1g(83%수율, mp 86-88)의 생성물을 얻는다.15.1 g (83% yield, mp 86-88) are obtained.

NMR(CDCl,) δ 2.31(t, 1H), 3.00-3.12(m, 3H), 4.70(t, 1H), 4.85(q, 1H), 5.09(d, 2H, J=6㎐), 6.9(t, 2H), 7.1-7.33(m, 8H), 7.48-7.67(m, 6H)NMR (CDCl,) δ 2.31 (t, 1H), 3.00-3.12 (m, 3H), 4.70 (t, 1H), 4.85 (q, 1H), 5.09 (d, 2H, J = 6Hz), 6.9 ( t, 2H), 7.1-7.33 (m, 8H), 7.48-7.67 (m, 6H)

Claims (5)

다음 구조식(Ⅱ)의 화합물을 트리풀루오로메틸 벤젠 할라이드와 반응시켜서 다음 구조식(Ⅰ)의 화합물을 제조하는 방법.A process for preparing a compound of formula (I) by reacting a compound of formula (II) with trifuluromethyl benzene halide. 다음 구조식(Ⅱ)의 화합물.A compound of formula (II) 다음 구조식(Ⅲ)의 화합물을 가수분해시켜서 다음 구조식(Ⅱ)의 화합물을 제조하는 방법.A process for preparing the compound of formula II by hydrolysis of the compound of formula III. 식중 R은 탄소수 1-4의 저급알킬기이다.R is a lower alkyl group having 1-4 carbon atoms. 다음 구조식(Ⅲ)의 화합물.The compound of formula (III) 식중 R은 탄소수 1-4의 저급알킬기이다.R is a lower alkyl group having 1-4 carbon atoms. 다음 구조식(Ⅳ)의 화합물을 4-하이드록시쿠마린과 반응시켜서 다음 구조식(Ⅲ)의 화합물을 제조하는 방법.A method of preparing the compound of formula III by reacting the compound of formula IV with 4-hydroxycoumarin. 식중 R은 탄소수 1-4의 저급알킬기이다.R is a lower alkyl group having 1-4 carbon atoms.
KR1019910015769A 1991-09-10 1991-09-10 Process for preparing raticide 4-hydroxy coumarin derivatives KR920006783B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019910015769A KR920006783B1 (en) 1991-09-10 1991-09-10 Process for preparing raticide 4-hydroxy coumarin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019910015769A KR920006783B1 (en) 1991-09-10 1991-09-10 Process for preparing raticide 4-hydroxy coumarin derivatives

Publications (1)

Publication Number Publication Date
KR920006783B1 true KR920006783B1 (en) 1992-08-17

Family

ID=19319776

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910015769A KR920006783B1 (en) 1991-09-10 1991-09-10 Process for preparing raticide 4-hydroxy coumarin derivatives

Country Status (1)

Country Link
KR (1) KR920006783B1 (en)

Similar Documents

Publication Publication Date Title
US4739101A (en) Method for the preparation of fibrates
CA1304088C (en) Heteroaryl compounds for treatment of inflammation and allergies
CA2658652C (en) Novel process for the synthesis of (e)-stilbene derivatives which makes it possible to obtain resveratrol and piceatannol
US4927956A (en) 3,5-disubstituted-4-acetoxystyrene and process for its production
US4965400A (en) Preparation of 3,5-disubstituted-4-acetoxystyrene
KR920006783B1 (en) Process for preparing raticide 4-hydroxy coumarin derivatives
US7321044B2 (en) Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens
CA1099709A (en) 5-(quaternary alkyl) resorcinol preparation and intermediates therefor
EP0309626B1 (en) Process for the preparation of dibenzothiepin derivative
US4891433A (en) Process for the preparation of dibenzothiepin derivative
US4201870A (en) Process for the preparation of 2-(3-benzoylphenyl)-propionic acid
KR100353536B1 (en) Method for preparing substituted phenylacetic acid derivatives and new intermediates
EP0052280B1 (en) Process for the production of 3-amino-4,6-diacetyl phenol or a derivative thereof
US5072025A (en) Process for the production of 3,5-disubstituted-4-acetoxystyrene
JP2549997B2 (en) New haloketal compound
JPS644508B2 (en)
CA1197511A (en) Haloalkyl-8-4h-¬1|-benzopyran-4-ones and process for preparing the same
FI81337B (en) FOERFARANDE FOER FRAMSTAELLNING AV 2- (PARA-SUBSTITUERAD FENOXI) -2-ALKYLPROPIONSYROR OCH DERAS ALKYLESTRAR.
KR100327554B1 (en) Improved manufacturing method of 4-hydroxythiocoumarin derivative, an anticoagulant killing agent
AU765927B2 (en) A process for the preparation of alpha-arylalkanoic acids
JP2815988B2 (en) Method for producing 3-N-cyclohexylaminophenol derivative
US4365072A (en) Biphenyl aldehydes
JP3118596B2 (en) Method for producing aryldialkylthiocarbamate, 2-mercaptobenzaldehyde and 2-substituted benzo [b] thiophene
US6806395B2 (en) Process for preparation of 3,5-bisalkylphenols
US4667056A (en) Process for preparing hydratropic acids and esters thereof, from propiphenones

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20110816

Year of fee payment: 20

EXPY Expiration of term